Cited by 175Artificial Intelligence in Healthcare and EducationAI in cancer detectionMultimodal Machine Learning Applications

Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology

Open access
Ferber, Dyke, El Nahhas, Omar S. M., Wölflein, Georg, Wiest, Isabella C., Clusmann, Jan, Leßmann, Marie-Elisabeth, Foersch, Sebastian, Lammert, Jacqueline +6 more·2025·Nature Cancer

Abstract

Clinical decision-making in oncology is complex, requiring the integration of multimodal data and multidomain expertise. We developed and evaluated an autonomous clinical artificial intelligence (AI) agent leveraging GPT-4 with multimodal precision oncology tools to support personalized clinical decision-making. The system incorporates vision transformers for detecting microsatellite instability and KRAS and BRAF mutations from histopathology slides, MedSAM for radiological image segmentation and web-based search tools such as OncoKB, PubMed and Google. Evaluated on 20 realistic multimodal patient cases, the AI agent autonomously used appropriate tools with 87.5% accuracy, reached correct clinical conclusions in 91.0% of cases and accurately cited relevant oncology guidelines 75.5% of the time. Compared to GPT-4 alone, the integrated AI agent drastically improved decision-making accuracy from 30.3% to 87.2%. These findings demonstrate that integrating language models with precision oncology and search tools substantially enhances clinical accuracy, establishing a robust foundation for deploying AI-driven personalized oncology support systems.

AI snapshot

Written from the paper’s full text.

TL;DR

The paper develops and evaluates an autonomous clinical AI agent that combines GPT-4 with multimodal precision oncology tools and retrieval-augmented generation to support personalized oncology decision-making. On 20 simulated multimodal patient cases, the agent improved decision-making accuracy over GPT-4 alone from 30.3% to 87.2%.

Key findings

  • The agent autonomously used appropriate tools with 87.5% accuracy: 56/64 required tool invocations ran successfully, with no failures among required tools; 8/64 required tools were unused, and two superfluous tool calls failed.
  • It reached correct clinical conclusions in 91.0% of cases: 223/245 assessable statements were factually correct, 16/245 (6.5%) were incorrect, and 6/245 (2.4%) were flagged as potentially harmful. Completeness was 87.2% versus 30.3% for GPT-4 alone, with only 14 expected answers not covered.
  • Citation accuracy was 75.5%: of 257 citations, 194 were accurately aligned with the model’s assertions, 59 (23.0%) were unrelated, and 4 (1.6%) conflicted with the model’s statement. Helpfulness was 63/67 (94.0%) subquestions effectively addressed.
  • Open-weight comparators performed poorly: Llama-3 70B had a 39.1% overall tool success rate and Mixtral 8x7B 7.8%; required tools remained unused for 18.8% (Llama) and 42.2% (Mixtral), and required-but-failed calls occurred for 42.2% (Llama) and 50.0% (Mixtral). Llama made 62 unnecessary failed tool calls across the 20 cases.

Methods

  • Design: proof-of-concept GPT-4-based agent using retrieval-augmented generation and tools including GPT-4 Vision, MedSAM, in-house vision transformers for MSI/MSS and KRAS/BRAF mutation detection from histopathology, a calculator, Google/PubMed search, and OncoKB. The knowledge database comprised roughly 6,800 medical documents and clinical scores from six official sources.
  • Data/sample: 20 realistic, fictional multimodal patient cases focused on gastrointestinal oncology, including colorectal, pancreatic, cholangiocellular, and hepatocellular cancers, with CT/MRI slices and TCGA histology images. Evaluation included 109 expected statements, 67 queries, 245 assessable response statements, and 257 citations; robustness testing used 300 combinations of age, sex, and origin.
  • Analysis: blinded manual evaluation by four certified clinicians with oncology expertise, using majority vote and selecting the least favorable outcome in ties. Metrics covered tool use, correctness, completeness, helpfulness, and citation correctness; GPT-4 alone and Llama-3 70B/Mixtral 8x7B were benchmarked.

Limitations

  • Stated: the most notable limitation is the small evaluation sample size (n = 20), making this a proof-of-concept study; individual tools need better independent optimization and validation; MedSAM lacked annotated ground-truth segmentation masks; vision transformers were trained/tested on TCGA data and some radiology images may have been in GPT-4V pretraining; the agent remains experimental, uses only a single radiology slice, has limited GPT-4V image interpretation, is confined to a single interaction rather than multiturn use, and is restricted to oncology. GPT-4’s cloud-based nature is unsuitable for real-world data protection, and deployment faces interoperability, privacy, liability, and regulatory challenges.
  • Stated: retrieval could be improved with domain-specific embedding/reranking models, hybrid search, larger context windows, and better handling of temporal treatment dependencies.
  • Evident from the text: no formal statistical testing was performed, sample size was not predetermined, experiments were not randomized, investigators were not blinded to allocation during experiments and outcome assessment, and experiments were limited to n = 1 per case because of rate/access limitations. Reproducibility may be affected by silent model changes or deprecations, and built-in guardrails occasionally caused refusals that were rerun until no refusal occurred.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s43018-025-00991-6

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 28 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    On 20 realistic multimodal patient cases, the AI agent autonomously used appropriate tools with 87.5% accuracy.

    “Evaluated on 20 realistic multimodal patient cases, the AI agent autonomously used appropriate tools with 87.5% accuracy”
    • Also stated in: § GPT-4 handles complex chains of tool use · plain
      “Of 64 required tool invocations to fully solve all given patient cases, the agent correctly used 56, achieving an overall success rate of 87.5%, with no failures among the required tools.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • Findingown data

    The AI agent reached correct clinical conclusions in 91.0% of cases.

    “reached correct clinical conclusions in 91.0% of cases”
    • Also stated in: § Evaluations show accurate, helpful and reliable responses · plain
      “Our evaluations found 223 (91.0%) of these to be factually correct”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
    • Rests on an assumption: The human experts’ predetermined expected answers and keywords, and their majority-vote evaluations, constitute a valid ground truth for correctness, completeness, helpfulness and citation accuracy.
  • Findingown data

    Compared to GPT-4 alone, the integrated AI agent improved decision-making accuracy from 30.3% to 87.2%.

    “Compared to GPT-4 alone, the integrated AI agent drastically improved decision-making accuracy from 30.3% to 87.2%.”
    • Also stated in: § Tool use and retrieval improve LLM responses · plain
      “GPT-4 alone only provided 30.3% of the expected answers. However, our agent’s responses achieved a 87.2% success rate”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
    • Rests on an assumption: The human experts’ predetermined expected answers and keywords, and their majority-vote evaluations, constitute a valid ground truth for correctness, completeness, helpfulness and citation accuracy.
  • Findingown data

    The AI agent accurately cited relevant oncology guidelines 75.5% of the time.

    “accurately cited relevant oncology guidelines 75.5% of the time”
    • Also stated in: § Evaluations show accurate, helpful and reliable responses · plain
      “of the 257 citations provided in the models’ responses, 194 (75.5%) were accurately aligned with the model’s assertions”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
    • Rests on an assumption: The human experts’ predetermined expected answers and keywords, and their majority-vote evaluations, constitute a valid ground truth for correctness, completeness, helpfulness and citation accuracy.
  • Findingown data

    There were two instances where the model tried to call superfluous tools without the necessary data available, which resulted in failures.

    “There were two instances where the model tried to call superfluous tools without the necessary data available, which resulted in failures”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims. 33
  • Classified as probably not a substantial claim. 47
  • May combine two claims.

    Findingown data

    GPT-4 alone only generates very generic or wrong responses.

    “As we have shown, GPT-4 alone only generates very generic or wrong responses.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    For patient W, the model used vision transformer models to assess the patient's mutational status, confirming the presence of a suspected BRAF mutation, and then queried OncoKB for management information.

    “for patient W (Supplementary Note 2), the model used vision transformer models to assess the patient’s mutational status, confirming the presence of a suspected BRAF mutation. The model then queried the OncoKB database to retrieve medical information on appropriate management regarding the mutation.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    Llama frequently used superfluous tools, including random calculations on nonsense values or hallucinating tumor locations during imaging analysis, leading to 62 unnecessary tool calls and failures across all 20 patient cases.

    “we saw that the Llama model frequently used superfluous tools, for example, performing random calculations on nonsense values or hallucinating (inventing) tumor locations during imaging analysis that did not exist. This led to 62 unnecessary tool calls and failures (‘not required, failed’) across all 20 patient cases evaluated.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    Of 64 required tool invocations, the agent correctly used 56, achieving an overall success rate of 87.5%, with no failures among the required tools.

    “Of 64 required tool invocations to fully solve all given patient cases, the agent correctly used 56, achieving an overall success rate of 87.5%, with no failures among the required tools.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    Mixtral frequently disregarded tool use, resulting in fewer than one in ten tools running successfully.

    “The major shortcoming of the Mixtral model was its frequent disregard for tool use, resulting in fewer than one in ten tools running successfully.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    For patient G, GPT-4 invoked MedSAM twice to obtain segmentation masks from two images at different time points and used the calculator to determine that the tumor had grown by a factor of 2.14.

    “in the tool results for patient G in Supplementary Note 2, GPT-4 invoked the MedSAM tool twice to obtain segmentation masks from two images taken at different time points. Subsequently, GPT-4 used the calculator function with the appropriate values from MedSAM to determine that the tumor had grown by a factor of 2.14.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    In three examples, tools and retrieval enabled the LLM to accurately solve cases, whereas GPT-4 alone either stated it could not solve the patient case and provided hypothetical answers or drew incorrect conclusions.

    “in Fig. 2a, we highlight three examples where tools and retrieval enabled the LLM to accurately solve cases, whereas, without these enhancements, GPT-4 either stated that it could not solve the patient case and provided hypothetical answers instead or drew incorrect conclusions”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    The agent was capable of resolving issues even when contradictory information was provided in a patient's description, such as discrepancies in reported mutations versus testing results; it pointed out inconsistencies, recommended further genetic confirmation and outlined potential treatment options.

    “the agent was capable of resolving issues, even in instances where contradictory information was provided in a patient’s description, such as discrepancies in reported mutations versus results of testing such mutations using tools. In such cases, the agent pointed out these inconsistencies, recommended further genetic confirmation and outlined potential treatment options based on the results (pat”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    The agent's responses achieved an 87.2% success rate, with only 14 instances not being covered.

    “However, our agent’s responses achieved a 87.2% success rate, with only 14 instances not being covered”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
    • Rests on an assumption: The human experts’ predetermined expected answers and keywords, and their majority-vote evaluations, constitute a valid ground truth for correctness, completeness, helpfulness and citation accuracy.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given

    Built-in guardrails designed to prevent potentially harmful content occasionally led to refusals and to inadequately addressing medical queries.

    “Additionally, built-in guardrails designed to prevent potentially harmful content occasionally led to refusals and to inadequately addressing medical queries.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Both models struggle to identify necessary tools for a given patient context, with 18.8% of required tools remaining unused by Llama and 42.2% for Mistral.

    “First, both models struggle to identify necessary tools for a given patient context (18.8% of required tools remain unused by Llama and even 42.2% for Mistral).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    Both open-weight models Llama-3 70B and Mixtral 8x7B demonstrate only extremely poor function-calling performance.

    “Overall, our findings reveal that both open-weight models demonstrate only extremely poor function-calling performance.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • May combine two claims.

    Findingown data

    Of 257 citations, 194 (75.5%) were accurately aligned with the model's assertions, 59 (23.0%) were unrelated, and 4 (1.6%) were in conflict with the model's statement.

    “of the 257 citations provided in the models’ responses, 194 (75.5%) were accurately aligned with the model’s assertions, while 59 (23.0%) were found to be unrelated and merely 4 (1.6%) were found to be in conflict with the model’s statement.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
    • Rests on an assumption: The human experts’ predetermined expected answers and keywords, and their majority-vote evaluations, constitute a valid ground truth for correctness, completeness, helpfulness and citation accuracy.
  • May combine two claims.

    Findingown data

    For Llama and Mixtral, overall tool success rates were 39.1% and 7.8%, respectively.

    “Consequently, for Llama and Mixtral, the overall success rates were low, registering only 39.1% (Llama) and 7.8% (Mixtral) (‘required, successful’).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • Classified as probably not a substantial claim. May combine two claims.

    Findingreasoning

    The decision regarding the use and timing of tools is dependent only on the agent's reasoning, unlike the retrieval phase which was manually enforced at each invocation.

    “Unlike the retrieval phase, which we manually enforced at each invocation, the decision regarding the use and timing of tools is dependent only on the agent’s reasoning.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Of 245 assessable statements, 223 (91.0%) were factually correct, 16 (6.5%) were incorrect, and 6 (2.4%) were flagged as potentially harmful.

    “resulting in a total of 245 assessable statements. Our evaluations found 223 (91.0%) of these to be factually correct and 16 (6.5%) to be incorrect, while 6 (2.4%) were flagged as potentially harmful.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
    • Rests on an assumption: The human experts’ predetermined expected answers and keywords, and their majority-vote evaluations, constitute a valid ground truth for correctness, completeness, helpfulness and citation accuracy.
  • May combine two claims.

    Findingreasoning

    GPT-4 can track the results from MedSAM back to the original image date because it has access to image file names that are based on date, ensuring accurate decision-making of lesion development over time.

    “GPT-4 can track the results from MedSAM back to the original image date, as it has access to image file names that are based on date. This capability ensures accurate decision-making of lesion development over time.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    All necessary information for calling the designated tools is derivable or producible from the given patient context.

    “All necessary information for calling the designated tools is derivable or producible from the given patient context.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In oncology, LLMs can serve as a rapid and reliable reference tool, for example by providing medical recommendation suggestions from official medical guidelines.

    “In oncology, where clinical decision-making is increasingly complex, LLMs can serve as a rapid and reliable reference tool, for instance, by providing medical recommendation suggestions from official medical guidelines4.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [4] Ferber, D. et al. GPT-4 for information retrieval and comparison of medical oncology guidelines. NEJM AI 1, AIcs2300235 (2024). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Several multimodal AI systems have been introduced, including models that analyze radiology images together with clinical data or integrate histopathology with genomic or text-based information.

    “Recently, several such AI systems have been introduced6. Examples include models that analyze radiology images together with clinical data7 or integrate information from histopathology with genomic8 or text-based information9.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [6] Lipkova, J. et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell 40, 1095–1110 (2022). source

      Not checked in the free run.

    • cites [7] Khader, F. et al. Multimodal deep learning for integrating chest radiographs and clinical parameters: a case for transformers. Radiology 309, e230806 (2023). source

      Not checked in the free run.

    • cites [8] Chen, R. J. et al. Pan-cancer integrative histology-genomic analysis via multimodal deep learning. Cancer Cell 40, 865–878 (2022). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    GPT-4 has achieved a passing score on the United States Medical Licensing Examination and can provide detailed explanations for its responses.

    “GPT-4 has achieved a passing score on the United States Medical Licensing Examination and is able to provide detailed explanations for its responses3.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [3] Nori, H., King, N., McKinney, S. M., Carignan, D. & Horvitz, E. Capabilities of GPT-4 on medical challenge problems. Preprint at https://doi.org/10.48550/arXiv.2303.13375 (2023). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Premisenone given

    The distribution of human diseases is wide and complex and is not captured in current performance benchmarks, where models are predominantly evaluated on a single specific task at a time.

    “The distribution of human diseases is wide and complex, which is not captured in current performance benchmarks, where these models are predominantly evaluated on a single specific task at a time.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Previous work has shown that limitations of LLMs can partially be overcome by enriching them with domain-specific information through fine-tuning or retrieval-augmented generation.

    “Previous work has shown that some of these limitations can partially be overcome by enriching LLMs with domain-specific information. This can be achieved through fine-tuning14 or retrieval-augmented generation (RAG)15”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [14] Chen, Z. et al. MEDITRON-70B: scaling medical pretraining for large language models. Preprint at https://doi.org/10.48550/arXiv.2311.16079 (2023). source

      Not checked in the free run.

    • cites [15] Lewis, P. et al. Retrieval-augmented generation for knowledge-intensive NLP tasks. In NIPS '20: Proc. 34th International Conference on Neural Information Processing Systems 793, 9459–9474 (2020).

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    RAG temporarily enhances an LLM's knowledge by incorporating relevant text excerpts from authoritative sources into the model.

    “retrieval-augmented generation (RAG)15, a process that temporarily enhances an LLM’s knowledge by incorporating relevant text excerpts from authoritative sources into the model, such as medical guidelines16 or textbooks.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [15] Lewis, P. et al. Retrieval-augmented generation for knowledge-intensive NLP tasks. In NIPS '20: Proc. 34th International Conference on Neural Information Processing Systems 793, 9459–9474 (2020).

      Not checked in the free run.

    • cites [16] Zakka, C. et al. Almanac—retrieval-augmented language models for clinical medicine. NEJM AI 1, AIoa2300068 (2024). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Premisecitation

    The future of medical artificial intelligence is multimodal.

    “the future of medical artificial intelligence (AI) is multimodal5.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [5] Acosta, J. N., Falcone, G. J., Rajpurkar, P. & Topol, E. J. Multimodal biomedical AI. Nat. Med. 28, 1773–1784 (2022). source

      Not checked in the free run.

  • May combine two claims.

    Study design and conductown data

    The study does not possess annotated ground-truth segmentation masks for comparison to MedSAM but uses clinical endpoints such as progressive disease or tumor shrinkage as the primary metric to measure outcomes.

    “we do not possess annotated ground-truth segmentation masks for comparison to MedSAM but use clinical endpoints such as progressive disease or tumor shrinkage as our primary metric to measure outcomes”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductcitation

    A notable restriction is the provision of only a singular slice of radiology images and the yet limited capabilities of GPT-4V in interpreting medical images.

    “One notable restriction for instance lies in the provision of only a singular slice of radiology images and the yet limited capabilities of GPT-4V (ref. 32) in interpreting medical images.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [32] OpenAI. GPT-4V(ision) system card. Available online at https://cdn.openai.com/papers/GPTV_System_Card.pdf (2023).

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The investigators were not blinded to allocation during experiments and outcome assessment.

    “The investigators were not blinded to allocation during experiments and outcome assessment; however, they were blinded to the model responses while establishing the ground truth for the necessity of tool use and the completeness of the responses.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation

    Combining precision medicine tools with an LLM enhances its capabilities in problem solving, aligning with the concept of using LLMs as 'reasoning engines'.

    “Our results demonstrate that combining precision medicine tools with an LLM enhances its capabilities in problem solving, aligning with the concept of using LLMs as ‘reasoning engines’ (ref. 30).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [30] Truhn, D., Reis-Filho, J. S. & Kather, J. N. Large language models should be used as scientific reasoning engines, not knowledge databases. Nat. Med. 29, 2983–2984 (2023). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    The model was programmatically configured to incorporate citations for each statement (maximum two consecutive sentences) using DSPy suggestions.

    “the model was programmatically configured to incorporate citations for each statement (as defined as a maximum of two consecutive sentences) using DSPy suggestions49.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The investigators were blinded to the model responses while establishing the ground truth for the necessity of tool use and the completeness of the responses.

    “The investigators were not blinded to allocation during experiments and outcome assessment; however, they were blinded to the model responses while establishing the ground truth for the necessity of tool use and the completeness of the responses.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Vision transformers in the study were trained and tested on data from The Cancer Genome Atlas (TCGA).

    “vision transformers in our study were trained and tested on data from The Cancer Genome Atlas (TCGA)”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Arasteh et al. used the integrated data analysis tools of an LLM to analyze scientific data, achieving results on par with human researchers.

    “Arasteh et al. used the integrated data analysis tools of an LLM to analyze scientific data, achieving results on par with human researchers19.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [19] Tayebi Arasteh, S. et al. Large language models streamline automated machine learning for clinical studies. Nat. Commun. 15, 1603 (2024). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Integrating three core elements (a reasoning engine, a knowledge database and tools) enables effectively addressing the limitation of GPT-4 alone, greatly improving accuracy and reliability.

    “However, integrating three core elements (a reasoning engine, a knowledge database and tools) enables us to effectively address this limitation, greatly improving accuracy and reliability.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationreasoning

    The modular approach offers far superior explainability compared to a large, generalist black-box model, as physicians can investigate the output from each individual tool separately.

    “Crucially, this modular approach also offers far superior explainability compared to a large, generalist black-box model, as physicians can investigate the output from each individual tool separately.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationnone given

    Individual tools require better independent optimization and validation.

    “it is essential to recognize that individual tools require better independent optimization and validation.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Reproducibility of the study's findings may be affected by silent changes implemented to the model by its developers and potential future model deprecations.

    “Reproducibility of the study’s findings may be affected by silent changes implemented to the model by its developers, which may not always be publicly disclosed, as well as by potential future model deprecations.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    In instances of refusal, each sample was rerun in newly instantiated settings until no such refusals occurred.

    “In these instances, we reran each sample in newly instantiated settings until no such refusals occurred.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Previous work already showed that LLMs can reliably identify temporal differences in medical documents.

    “Previous work already showed that LLMs can reliably identify temporal differences in medical documents4.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [4] Ferber, D. et al. GPT-4 for information retrieval and comparison of medical oncology guidelines. NEJM AI 1, AIcs2300235 (2024). source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The pipeline is able to autonomously handle multiple steps, including determining the need for specific tools, locating relevant data, understanding chronological order, sending requests, receiving results and integrating these into next steps, without human supervision.

    “we show that our pipeline is able to autonomously handle multiple steps, such as determining the need for specific tools, locating the relevant data, understanding their chronological order, sending requests to the appropriate tool, receiving results and integrating these into the next steps of its decision-making”
    • Also stated in: § Radiology tools improve GPT-4’s treatment accuracy · plain
      “All of these steps are managed fully autonomously, without human supervision, by the LLM agent.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    No data were excluded in the analysis.

    “No data were excluded in the analysis.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Study design and conductnone given

    Some radiology images available online may have been included in the pretraining of GPT-4V.

    “some radiology images available online may have been included in the pretraining of GPT-4V.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The vision tool approach is currently restricted to single-slice images that need to be taken at the same magnification.

    “A potential limitation of the vision tool approach is that, for both scenarios, we currently restrict the use to single-slice images that additionally need to be taken at the same magnification.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The overall analysis was approved by the Ethics Commission of the Medical Faculty of the Technical University Dresden (BO-EK-444102022).

    “The overall analysis was approved by the Ethics Commission of the Medical Faculty of the Technical University Dresden (BO-EK-444102022).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The evaluation is currently confined to a single interaction.

    “despite being implemented as a multiturn chat agent, our evaluation is currently confined to a single interaction.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    GPT-4 with tools and RAG can deliver highly accurate, helpful and well-cited responses, enhancing its ability to handle complex medical scenarios and provide support for clinical decision-making.

    “Overall, our results show that GPT-4 with tools and RAG can deliver highly accurate, helpful and well-cited responses, which enhances its ability to handle complex medical scenarios and provide support for clinical decision-making.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The study used generalist embedding, retrieval and reranking models.

    “we used generalist embedding, retrieval and reranking models”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Existing biomedical benchmarks and evaluation datasets are designed for one or two data modalities and are restricted to closed question-and-answer formats.

    “Existing biomedical benchmarks and evaluation datasets are designed for one or two data modalities26 and are restricted to closed question-and-answer formats.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [26] He, X., Zhang, Y., Mou, L., Xing, E. & Xie, P. PathVQA: 30000+ questions for medical visual question answering. Preprint at https://doi.org/10.48550/arXiv.2003.10286 (2020). source

      Not checked in the free run.

  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    For all benchmarks, the majority vote was reported; in cases of a tie, the most adverse outcome was selected according to a hierarchical schema.

    “For all benchmarks, we reported the majority vote. In cases of a tie, we selected the most adverse outcome, adhering to a hierarchical schema: correct, irrelevant and wrong for citations and correct, wrong and harmful for the correctness evaluation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    By prioritizing clinical endpoints to validate the agent pipeline, the study can offer new, directly relevant evidence and metrics to address the current scarcity of objective measures for AI agents in healthcare.

    “Overall, we believe that, by prioritizing clinical endpoints to validate our agent pipeline, we can offer new, directly relevant evidence and metrics to address the current scarcity of objective measures for AI agents in healthcare.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    Experiments were limited to n = 1 per case because of stringent rate and access limitations at the time of experimentation.

    “Experiments were limited to n = 1 per case because of stringent rate and access limitations at the time of experimentation, when access to GPT-4V was available only as a preview.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Study design and conductnone given

    The current agent architecture is a static design choice.

    “Moreover, our current agent architecture is a static design choice.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    In-house CT/MRI slices were selected by an experienced radiologist from the team who was blinded to the rest of the study at the time of image selection.

    “Our in-house slices were selected by an experienced radiologist from our team, who was blinded to the rest of the study at the time of image selection.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Study design and conductnone given

    Current regulatory restrictions make GPT-4 unsuitable for real-world settings because of its cloud-based nature, which necessitates transferring sensitive patient data to proprietary commercial servers.

    “current regulatory restrictions make GPT-4 unsuitable because of its cloud-based nature, which necessitates transferring sensitive patient data to proprietary commercial servers.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    The approach demonstrates a high capability in delivering accurate answers, supported by relevant citations from authoritative sources, which facilitates quick fact-checking as the agent returns the exact original text from the guideline documents.

    “We show that our approach demonstrates a high capability in delivering accurate answers, supported by relevant citations from authoritative sources, which also facilitates quick fact-checking as the agent returns the exact original text from the guideline documents.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Our study provides evidence that agent-based generalist medical AI is within reach.

    “Herein, our study could serve as a blueprint, providing evidence that agent-based generalist medical AI is within reach.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    No statistical methods were used to predetermine sample sizes.

    “No statistical methods were used to predetermine sample sizes.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    All evaluations were performed independently by four certified clinicians with expertise in oncology.

    “All evaluations described here were performed independently by four certified clinicians with expertise in oncology.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    Experiments were not randomized, as only one test group (the AI agent) existed in this proof-of-concept study.

    “Experiments were not randomized, as only one test group (the AI agent) existed in this proof-of-concept study.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The work is considered a proof-of-concept study for agentic AI workflows in oncology.

    “We, therefore, consider our work as a proof-of-concept study for agentic AI workflows in oncology and encourage future efforts to develop larger-scale benchmark cases.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The patient scenarios were restricted to oncological use cases only.

    “we restricted our patient scenarios to oncological use cases only”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Xiong et al. demonstrated that domain-specific models can enhance retrieval performance.

    “Xiong et al.37 demonstrated that domain-specific models can enhance retrieval performance.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [37] Xiong, G., Jin, Q., Lu, Z. & Zhang, A. Benchmarking retrieval-augmented generation for medicine. Preprint at https://doi.org/10.48550/arXiv.2402.13178 (2024). source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    For rare terms, exact match keyword searches can outperform similarity searches in embedding space and both can be combined (hybrid search).

    “for rare terms (such as rare diseases), exact match keyword searches can outperform similarity searches in embedding space and both can even be combined (also termed hybrid search38).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [38] Bruch, S., Gai, S. & Ingber, A.An analysis of fusion functions for hybrid retrieval. ACM Trans. Inf. Syst. 42, 1–35 (2023).

      Not checked in the free run.

  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    This study did not include confidential patient information; all research procedures were conducted exclusively on publicly accessible, anonymized patient data and in accordance with the Declaration of Helsinki.

    “This study did not include confidential patient information. All research procedures were conducted exclusively on publicly accessible, anonymized patient data and in accordance with the Declaration of Helsinki, maintaining all relevant ethical standards.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    The results are expected to remain reproducible when using other current state-of-the-art models.

    “Despite these factors, the results are expected to remain reproducible when using other current state-of-the-art models.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    The RAG framework synergizes the generative capabilities of LLMs with document retrieval to provide domain-specific medical knowledge (context) to a model.

    “We leveraged RAG to synergize the generative capabilities of LLMs with document retrieval to provide domain-specific medical knowledge (context) to a model.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [15] Lewis, P. et al. Retrieval-augmented generation for knowledge-intensive NLP tasks. In NIPS '20: Proc. 34th International Conference on Neural Information Processing Systems 793, 9459–9474 (2020).

      Not checked in the free run.

  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Recent datasets by Zakka et al. target open-ended responses and LongHealth focuses on patient-related content.

    “Recent advancements have been made with the introduction of new datasets by Zakka et al.16, targeting the enhancement of open-ended responses, and LongHealth27, focusing on patient-related content.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [16] Zakka, C. et al. Almanac—retrieval-augmented language models for clinical medicine. NEJM AI 1, AIoa2300068 (2024). source

      Not checked in the free run.

    • cites [27] Adams, L. et al. LongHealth: a question answering benchmark with long clinical documents. Preprint at https://doi.org/10.48550/arXiv.2401.14490 (2024). source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisereasoning

    The reranking step filters out passages that exhibit falsely high similarity (low distance) in embedding space but are contextually irrelevant.

    “This step filters out passages that exhibit falsely high similarity (low distance) in embedding space but are contextually irrelevant.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Each case provided a comprehensive but entirely fictional patient profile.

    “Each case provided a comprehensive but entirely fictional patient profile, which includes a concise medical history overview encompassing diagnoses, notable medical events and previous treatments.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    GROBID enables the effective parsing of medical documents, preserving text hierarchy and generating essential metadata such as document and journal titles, authorship, pagination, publication dates and download URLs.

    “Through its particular training on scientific and technical articles, GROBID enables the effective parsing of medical documents, preserving text hierarchy and generating essential metadata such as document and journal titles, authorship, pagination, publication dates and download URLs.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [46] Ide, N. & Véronis, J. (eds) Text Encoding Initiative (Springer, 1995). source

      Not checked in the free run.

70 of 70
  • The paper relies on this without support.

    The 20 simulated patient cases are realistic and representative enough of real-world oncology clinical decision-making for the agent’s performance to be meaningful.

    “Evaluated on 20 realistic multimodal patient cases”
    “we develop and assess our agent using a dataset comprising 20 realistic and multidimensional patient cases, which we generate with a focus on gastrointestinal oncology”
  • The paper relies on this without support.

    Real-world clinical decision-making often requires multistep reasoning, planning and repeated interactions with data to uncover new insights to make informed and personalized decisions.

    “In contrast, real-world clinical decision-making often requires multistep reasoning, planning and repeated interactions with data to uncover new insights to make informed and personalized decisions.”
  • The paper relies on this without support.

    The human experts’ predetermined expected answers and keywords, and their majority-vote evaluations, constitute a valid ground truth for correctness, completeness, helpfulness and citation accuracy.

    “Completeness’ (95/109) measures the proportion of experts’ expected answers, as predetermined by keywords, that the model accurately identifies or proposes.”
  • The paper relies on this without support.

    The precision oncology tools used (vision transformers, MedSAM and GPT-4V) produce sufficiently valid outputs for the agent’s clinical conclusions.

    “we do not possess annotated ground-truth segmentation masks for comparison to MedSAM but use clinical endpoints such as progressive disease or tumor shrinkage as our primary metric to measure outcomes”
    “vision transformers in our study were trained and tested on data from The Cancer Genome Atlas (TCGA)”
  • The paper relies on this without support.

    The repository of roughly 6,800 medical documents and clinical scores from six official sources is authoritative and sufficient to ground the model’s reasoning and citations.

    “we compile a repository of roughly 6,800 medical documents and clinical scores from a collection of six different official sources, specifically tailored to oncology.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ferber et al. (2025) developed an MAS that replicates a multi-disciplinary tumor board discussion by integrating multiple specialized agents for different data modalities and decision facets.

    “Ferber et al., (2025) developed an MAS that replicates a multi-disciplinary tumor board discussion by integrating multiple specialized agents for different data modalities and decision facets [34].”

    From A Review of Multi-Agent AI Systems for Biological and Clinical Data Analysis (2026) · cites this paper as [34]

    The Main section describes one GPT-4-based oncology agent that uses specialized tools for radiology, histopathology and information retrieval. The Methods section (Agent composition: tools; page unavailable) says that this agent plans and invokes the tools. The paper does not describe multiple collaborating agents or a replication of multidisciplinary tumor board discussion. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The agent accurately cited guidelines 75.5% of the time.

    “accurately cited guidelines 75.5% of the time”

    From A Review of Multi-Agent AI Systems for Biological and Clinical Data Analysis (2026) · cites this paper as [34]

    The Results (‘Evaluations show accurate, helpful and reliable responses’; page unavailable) report that 194 of 257 citations (75.5%) accurately aligned with the agent’s assertions. That percentage covers all evaluated citations, not a separately reported subset of citations to guidelines; the Methods (‘Dataset composition and data collection’) describe sources that include both guidelines and other medical resources. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The virtual tumor board system leverages GPT-4 as a core reasoning engine and incorporates specialized precision oncology tools, including vision transformers for detecting microsatellite instability (MSI) and mutations (KRAS, BRAF) from histopathology slides, MedSAM for radiological image segmentation, and web-based search tools like OncoKB and PubMed.

    “The system leverages GPT-4 as a core reasoning engine and incorporates specialized precision oncology tools, including vision transformers for detecting microsatellite instability (MSI) and mutations (KRAS, BRAF) from histopathology slides, MedSAM for radiological image segmentation, and web-based search tools like OncoKB and PubMed [34].”
  • Mixtral 8x7B had a success rate of 7.8% in the comparison.

    “Llama-3 70B and Mixtral 8x7B registered significantly lower success rates of 39.1% and 7.8%, respectively”
  • Llama-3 70B had a success rate of 39.1% in the comparison.

    “Llama-3 70B and Mixtral 8x7B registered significantly lower success rates of 39.1% and 7.8%, respectively”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • 91.0% is a statement-level result, not a case-level result

    Major

    The abstract reports correct clinical conclusions in 91.0% of cases, but the Results define 91.0% as 223 correct statements out of 245 assessable statements. The paper does not report that percentage for its 20 cases.

  • Patient images were not exclusively from publicly accessible data

    Minor

    The Methods say all research procedures used exclusively publicly accessible patient data, but later state that the imaging was predominantly obtained from internal hospital sources.

2 of 2

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Bruch, S., Gai, S. & Ingber, A.An analysis of fusion functions for hybrid retrieval. ACM Trans. Inf. Syst. 42, 1–35 (2023).

Cited by

Sorted by citations

Authors
Ferber, D., El Nahhas, O. S. M., Wölflein, G., Wiest, I. C., Clusmann, J., Leßmann, M.-E., Foersch, S., Lammert, J., Tschochohei, M., Jäger, D., Salto-Tellez, M., Schultz, N., Truhn, D., & Kather, J. N.
Affiliations
  • Heidelberg University (DE)
  • University of St Andrews (GB)
  • Universitätsklinikum Aachen (DE)
  • University Hospital Carl Gustav Carus (DE)
  • University Medical Center of the Johannes Gutenberg University Mainz (DE)
  • TUM Klinikum (DE)
  • Ludwig-Maximilians-Universität München (DE)
  • Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Kather, Jakob Nikolas
Venue
Nature Cancer
Published
2025-06-06
Volume
6
Issue
8
Pages
1337-1349
ISSN
2662-1347 (ISSN-L)
OpenAlex
W4411100445
Cited by
175
References
57
Citations by year
2026: 136 · 2025: 39
FWCI
41.83
Type
journal article
Language
en
Open access
Locations
  • Nature Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion, other-oa)
Funders
  • National Institute for Health and Care Research (NIHR213331)
  • Department of Health and Social Care
  • European Commission (101096312, 101057091)
  • Deutscher Akademischer Austauschdienst (57616814)
  • Deutsche Forschungsgemeinschaft (504101714)
  • Bundesministerium für Bildung und Forschung (01KD2215A, 01EO2101, 01VSF21048, 57616814, 01KD2215B, 01KD2104C, 031L0312A)
  • Bundesministerium für Gesundheit (ZMVI1-2520DAT111, 2520DAT111)
  • Deutsche Krebshilfe (70115166, #70113864, 2520DAT111)
  • Deutschen Konsortium für Translationale Krebsforschung
  • Gemeinsame Bundesausschuss (01VSF21048)
  • HORIZON EUROPE Framework Programme (101057091)
  • National Cancer Institute (P30CA008748)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Multimodal Machine Learning Applications
Keywords
clinical decision support, oncology, GPT-4, multimodal AI, precision oncology, KRAS mutation, BRAF mutation, histopathology, MedSAM, OncoKB, oncology guidelines
MeSH terms
Clinical Decision-Making, Artificial Intelligence, Humans, Medical Oncology, Mutation, Neoplasms, Proto-Oncogene Proteins p21(ras), Decision Support Systems, Clinical, Proto-Oncogene Proteins B-raf, Microsatellite Instability, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review